Not Tagged
biomea fusion,vaxcyte,cel-sci,plus therapuetics,praxis precision medicines,jazz pharma,exscientia
['$exai', '$pcvx', '$bmea', 'jazz', '$jazz', '$prax', '$cvm', '$pstv']
biotech news 4/19 $cvm 15% pursuing approval pathways
$bmea 9% late breaking data upcoming '23
$pcvx 5% $500m offering
$exai 6% data presentation '23
$pstv 3% complete enrollment in ph1/2a trial.
$lgvn 2% dosed in ph2
$prax 1% presentation '23
$jazz 1% 
Catalyst Calendar, Big Mover stocks to watch, & model portfolios. Database & tools to help with your biotech stock research. not investment advice. https://t.co/5njnanqtbK